Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform

NCT ID: NCT06930898

Last Updated: 2025-04-18

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 72 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-12-01
• Study Completion Date: 2025-03-24

Brief Summary

This randomized controlled trial aimed to evaluate the effectiveness of Mammoverse, a gamified metaverse-based educational platform, in improving breast health knowledge among women in China. Participants were randomly assigned to either a gamified or non-gamified version of the platform. Both groups received identical educational content, but only the gamified group experienced interactive game elements such as avatars, progress feedback, and rewards. Knowledge was assessed at baseline, immediately post-intervention, and at 4-week follow-up. The study found that the gamified platform significantly improved knowledge retention and participant engagement compared to the non-gamified version.

This ClinicalTrials.gov registration reflects only the randomized controlled trial (RCT) portion of a broader mixed-methods study that was approved by the University of Malaya Research Ethics Committee (Ref: UM.TNC2/UMREC_3967). The full study protocol includes three methodological approaches, and this registration pertains specifically to the RCT component involving the Mammoverse platform. Other study components are not included in this registration.

Detailed Description

Mammoverse is a 3D metaverse environment designed to promote breast health knowledge through immersive and interactive learning. The gamified version included user avatars, badges, tasks, and personalized feedback to increase motivation and engagement. The study recruited 72 women aged 18 and above, and used a pre-post-follow-up design. Outcome measures were based on an adapted 18-item Breast Health Literacy Questionnaire. The trial was conducted entirely online, with ethics approval from the University of Malaya Research Ethics Committee.

Conditions

Health Education; Breast Neoplasms

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Gamified Metaverse Education

Participants in this group used the Mammoverse platform with gamified features, including story-based missions, interactive tasks, point-based rewards, achievement badges, and virtual incentives. The educational content was delivered through immersive scenarios to enhance engagement and motivation in learning about breast health.

Group Type: EXPERIMENTAL

Gamified Mammoverse Platform

Intervention Type: BEHAVIORAL

A gamified, metaverse-based platform delivering breast health education through story-based tasks, interactive challenges, points, rewards, badges, and virtual incentives.

Non-Gamified Metaverse Education

Participants in this group accessed the Mammoverse platform without any gamified features. The virtual environment delivered identical breast health educational content, but without tasks, points, rewards, badges, or narrative elements.

Group Type: ACTIVE_COMPARATOR

Standard Mammoverse Platform

Intervention Type: BEHAVIORAL

A non-gamified version of the Mammoverse platform that provides the same breast health educational content.

Interventions

Gamified Mammoverse Platform

A gamified, metaverse-based platform delivering breast health education through story-based tasks, interactive challenges, points, rewards, badges, and virtual incentives.

Intervention Type: BEHAVIORAL

Standard Mammoverse Platform

A non-gamified version of the Mammoverse platform that provides the same breast health educational content.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Female participants aged 18 years and above
• Able to read and understand Chinese
• Access to a digital device and stable internet connection
• Willing to provide informed consent

Exclusion Criteria

• Cognitive impairment or mental health condition that affects participation
• Inability to complete the full intervention and follow-up sessions
• Incomplete baseline assessment

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

University of Malaya

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Rui Li, PhD(c)

Role: PRINCIPAL_INVESTIGATOR

University of Malaya

Locations

Online Recruitment - Hangzhou, Zhejiang, China

Hangzhou, Zhejiang, China

University of Malaya

Kuala Lumpur, , Malaysia

Countries

China; Malaysia

Other Identifiers

UMREC_3967

Identifier Type: OTHER

Identifier Source: secondary_id

Mammo2025-RCT01

Identifier Type: -

Identifier Source: org_study_id